Exit

Return to HIV Research Document Library

Category Legend

Study Type(s)

Topic Area(s)

Document Type(s)

Study Method(s)

Document Method(s)

PROBeX: Exit from Study SOP (1291)

PROBeX SOP TB/Coinfection Studies PROBeX HIV Follow-up Management Study Testing Drug Exclusion Withdrawal ART Treatment Africa Tuberculosis Patient Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Exit Death Lost Decision Termination Voluntarily Absence International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX exit from study SOP.

PROBeX: Study Exit CRF (1274)

PROBeX CRF TB/Coinfection Studies PROBeX Consent HIV Contact Testing Drug Withdraw ART Treatment Africa Tuberculosis Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Exit Final Reason Death Lost International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX participant exit CRF

PrEP@Home: Linkage to PrEP Care SOP (1101)

PREP at Home SOP PREP@Home Laboratory PrEP Participant Staff SOP System Behavioral Control Monitoring Linkage Care Persistence Remote Telemedicine Multi-Site Intervention Exit Completed Domestic 2023 PAH-Document Methods Clinical Prevention Behavioral Health Equity mHealth Clinical Standard RCT Clinical Qual + Quant

Linkage to PrEP care SOP for control and intervention participants who have finished the PrEP@Home Study.